Proteogenomic analysis of NCC-S1M, a gastric cancer stem cell-like cell line that responds to anti-PD-1

Biochem Biophys Res Commun. 2017 Mar 11;484(3):631-635. doi: 10.1016/j.bbrc.2017.01.153. Epub 2017 Jan 30.

Abstract

To elucidate signaling pathways that regulate gastric cancer stem cell (CSC) phenotypes and immune checkpoint, we performed a proteogenomic analysis of NCC-S1M, which is a gastric cancer cell line with CSC-like characteristics and is the only syngeneic gastric tumor cell line transplant model created in the scientific community. We found that the NCC-S1M allograft was responsive to anti-PD-1 treatment, and overexpressed Cd274 encoding PD-L1. PD-L1 was transcriptionally activated by loss of the TGF-β signaling. Il1rl1 protein was overexpressed in NCC-S1M cells compared with NCC-S1 cells that are less tumorigenic and less chemoresistant. Il1rl1 knockdown in NCC-S1M cells reduced tumorigenic potential and in vivo chemoresistance. Our proteogenomic analysis demonstrates a role of Smad4 loss in the PD-L1 immune evasion, as well as Il1rl1's role in CSC-like properties of NCC-S1M.

Keywords: Cancer; Ccne1; Gastric; Il1rl1; PD-L1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents
  • Carcinogenesis / drug effects
  • Carcinogenesis / immunology
  • Cell Line, Tumor
  • Gene Expression Profiling / methods
  • Gene Expression Regulation, Neoplastic / immunology
  • Mice
  • Neoplasm Proteins / immunology*
  • Neoplastic Stem Cells / classification
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / immunology*
  • Proteome / immunology*
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • Stomach Neoplasms / classification
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / immunology*

Substances

  • Antineoplastic Agents
  • Neoplasm Proteins
  • Proteome